StreetInsider
Log in to your account:
Log in
Signup
Home
EPS Insider
Event Calendar
Conferences
Classic Site
Upgrade to SI Premium - Free Trial
Valeant Pharma (VRX) Brodalumab Briefing Docs Posted; Concerns Linger
July 15, 2016 8:10 AM
Briefing docs for Valeant's (NYSE: VRX) brodalumab posted by the U.S. FDA. They ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
Categories
Short Sales
Trader Talk
Next Articles
Valeant Pharma (VRX) AdCom on Brodalumab Begins
July 19, 2016 8:10 AM
Briefing Docs Show Valeant Pharma (VRX) Brodalumab Prospects are Dim - Wells Fargo
July 15, 2016 1:09 PM
Valeant Pharma (VRX) Will Report Q2 Results on August 9th
July 15, 2016 8:05 AM
Valeant Pharmaceuticals Announces Second Quarter Results Conference Call Date And Details
July 15, 2016 8:00 AM
Valeant Pharma (VRX) Shares Look to Add to Yesterday's Gains Early
July 15, 2016 7:31 AM
Valeant (VRX) Investors Should Be Focused on Earnings Not Upcoming Product Catalysts - Wells Fargo
July 14, 2016 1:29 PM
